Tamura H - Search Results

1

Assessment of therapeutic potential of interleukin 2 for myelodysplastic syndromes.

Ogata K, Yokose N, Ito T, An E, Tamura H, Dan K, Hamaguchi H, Sakamaki H, Onozawa Y, Nomura T. Ogata K, et al. Among authors: tamura h. Br J Haematol. 1994 Mar;86(3):562-7. doi: 10.1111/j.1365-2141.1994.tb04787.x. Br J Haematol. 1994. PMID: 8043438

2

Thrombopoietin and myelodysplastic syndromes.

Ogata K, Tamura H. Ogata K, et al. Among authors: tamura h. Int J Hematol. 2000 Aug;72(2):173-7. Int J Hematol. 2000. PMID: 11039665 Review.

3

Effects of interleukin-12 on natural killer cell cytotoxicity and the production of interferon-gamma and tumour necrosis factor-alpha in patients with myelodysplastic syndromes.

Ogata K, Tamura H, Yokose N, An E, Dan K, Hamaguchi H, Sakamaki H, Onozawa Y, Clark SC, Nomura T. Ogata K, et al. Among authors: tamura h. Br J Haematol. 1995 May;90(1):15-21. doi: 10.1111/j.1365-2141.1995.tb03375.x. Br J Haematol. 1995. PMID: 7786778

4

Elevated plasma soluble interleukin 2 receptor level correlates with defective natural killer and CD8+ T-cells in myelodysplastic syndromes.

Yokose N, Ogata K, Ito T, An E, Tamura H, Dan K, Hamaguchi H, Sakamaki H, Onozawa Y, Nomura T. Yokose N, et al. Among authors: tamura h. Leuk Res. 1994 Oct;18(10):777-82. doi: 10.1016/0145-2126(94)90060-4. Leuk Res. 1994. PMID: 7934136

5

Defective natural killer (NK) cell-mediated cytotoxicity does not imply clonal involvement of NK cells in myelodysplastic syndromes.

Ogata K, Fujii H, Yokose N, An E, Tamura H, Kamikubo K, Dan K, Hamaguchi H, Sakamaki H, Onozawa Y, et al. Ogata K, et al. Among authors: tamura h. Br J Haematol. 1994 Jun;87(2):396-8. doi: 10.1111/j.1365-2141.1994.tb04928.x. Br J Haematol. 1994. PMID: 7947284

6

Plasma soluble interleukin-2 receptor level in patients with primary myelodysplastic syndromes: a relationship with disease subtype and clinical outcome.

Ogata K, Yokose N, An E, Kamikubo K, Tamura H, Dan K, Sakamaki H, Onozawa Y, Hamaguchi H, Nomura T. Ogata K, et al. Among authors: tamura h. Br J Haematol. 1996 Apr;93(1):45-52. doi: 10.1046/j.1365-2141.1996.4641003.x. Br J Haematol. 1996. PMID: 8611474

7

Cell cycle modulation by hematopoietic growth factors in myelodysplastic syndromes: analysis by three-color flow cytometry.

Ogata K, An E, Kamikubo K, Tamura H, Yokose N, Dan K, Nomura T. Ogata K, et al. Among authors: tamura h. Exp Hematol. 1997 Jan;25(1):8-18. Exp Hematol. 1997. PMID: 8989901

8

Plasma thrombopoietin (TPO) levels and expression of TPO receptor on platelets in patients with myelodysplastic syndromes.

Tamura H, Ogata K, Luo S, Nakamura K, Yokose N, Dan K, Tohyama K, Yoshida Y, Hamaguchi H, Sakamaki H, Kuwaki T, Tahara T, Kato T, Nomura T. Tamura H, et al. Br J Haematol. 1998 Dec;103(3):778-84. doi: 10.1046/j.1365-2141.1998.01054.x. Br J Haematol. 1998. PMID: 9858230 Free article.

9

Lineage-unrestricted hematologic response to granulocyte colony-stimulating factor in a patient with refractory anemia with excess blasts.

Yokose N, Ogata K, An E, Tamura H, Kamikubo K, Dan K, Nomura T. Yokose N, et al. Among authors: tamura h. Ann Hematol. 1995 Mar;70(3):163-7. doi: 10.1007/BF01682038. Ann Hematol. 1995. PMID: 7536478

10

Natural killer cells in the late decades of human life.

Ogata K, Yokose N, Tamura H, An E, Nakamura K, Dan K, Nomura T. Ogata K, et al. Among authors: tamura h. Clin Immunol Immunopathol. 1997 Sep;84(3):269-75. doi: 10.1006/clin.1997.4401. Clin Immunol Immunopathol. 1997. PMID: 9281385

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,927 results

Search Page

Filters